Obesity Injections Show Reduced Effectiveness in Real-World Settings
Originally Published 7 months ago — by NDTV
A study in the US suggests that anti-obesity injections like semaglutide and tirzepatide have less impact on weight loss in real-world settings compared to clinical trials, mainly due to higher discontinuation rates and lower maintenance doses, with factors such as cost, side effects, and medication shortages influencing adherence.